Insider Shareholders with Direct Ownership of Artivion, Inc. (AORT)
This section provides a comprehensive overview of the insiders with direct ownership of Artivion, Inc. (AORT). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
ARTIVION, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
James P Mackin
President & CEO |
808,343 | 367,055 | 705,562 $20.5 Million | 36 |
Mar 05, 2024
Reduced 1.95%
|
|
David Ashley Lee
Executive VP, COO & CFO |
182,434 | 100,224 | 347,217 $10.1 Million | 25 |
Mar 02, 2023
Reduced 0.4%
|
|
John E Davis
Chief Commercial Officer |
139,034 | 49,056 | 165,637 $4.8 Million | 29 |
Mar 05, 2024
Reduced 1.21%
|
|
Jean F Holloway
SVP, General Counsel |
161,976 | 78,264 | 153,862 $4.46 Million | 36 |
Dec 11, 2024
Reduced 2.56%
|
|
Scott B Capps
VP, Clinical Research |
16,724 | 10,527 | 153,203 $4.44 Million | 7 |
Mar 12, 2021
Reduced 0.15%
|
|
Daniel J Bevevino
Director |
28,299 | 0 | 143,736 $4.17 Million | 4 |
May 30, 2024
Added 4.19%
|
|
Thomas F Ackerman
Director |
28,299 | 0 | 143,571 $4.16 Million | 4 |
May 30, 2024
Added 4.2%
|
|
Amy Horton
VP, Chief Accounting Officer |
154,739 | 113,187 | 134,464 $3.9 Million | 46 |
Dec 12, 2024
Reduced 0.81%
|
|
Jon W Salveson
Director |
28,299 | 0 | 123,515 $3.58 Million | 4 |
May 30, 2024
Added 4.84%
|
|
Ronald D Mc Call
Director |
4,423 | 16,088 | 121,768 $3.53 Million | 4 |
Aug 25, 2021
Reduced 4.45%
|
|
Marshall S. Stanton
SVP, Clinical & MD Affair |
90,394 | 11,218 | 83,296 $2.42 Million | 15 |
Mar 20, 2024
Reduced 2.55%
|
|
Lance A Berry
Executive VP, CFO |
79,064 | 0 | 79,064 $2.29 Million | 2 |
Feb 23, 2024
Added 31.88%
|
|
James Bullock
Director |
28,299 | 0 | 62,322 $1.81 Million | 4 |
May 30, 2024
Added 9.17%
|
|
Harvey Morgan
Director |
4,423 | 5,725 | 50,768 $1.47 Million | 3 |
Aug 30, 2021
Reduced 6.7%
|
|
Jeffrey H Burbank
Director |
28,299 | 0 | 47,471 $1.38 Million | 4 |
May 30, 2024
Added 11.7%
|
|
Rochelle L. Maney
VP, Quality |
48,389 | 16,594 | 46,536 $1.35 Million | 21 |
Mar 05, 2024
Reduced 2.43%
|
|
Marna P Borgstrom
Director |
28,299 | 0 | 42,763 $1.24 Million | 4 |
May 30, 2024
Added 12.82%
|
|
Dennis B Maier
SVP, Operations |
63,635 | 49,443 | 34,724 $1.01 Million | 25 |
Jun 06, 2023
Reduced 1.08%
|
|
Anthony B. Semedo
Director |
43,868 | 9,709 | 34,159 $990,611 | 5 |
Aug 13, 2024
Reduced 22.13%
|
|
Matthew A Getz
VP, Human Resources |
63,453 | 32,546 | 34,116 $989,364 | 23 |
Aug 16, 2024
Reduced 6.99%
|
|
Michael S Simpson
SVP, Regulatory Affairs and QA |
10,436 | 1,204 | 33,698 $977,242 | 4 |
Mar 05, 2021
Reduced 0.89%
|
|
Andrew M Green
VP Regulatory |
53,673 | 20,206 | 33,503 $971,587 | 16 |
Dec 04, 2024
Reduced 18.53%
|
|
Franz Peter Barthold
VP, Research & Development |
29,908 | 4,325 | 32,516 $942,964 | 13 |
Nov 08, 2022
Added 27.79%
|
|
Elizabeth A Hoff
Director |
25,064 | 0 | 25,064 $726,856 | 3 |
May 30, 2024
Added 20.06%
|
|
Florian Tyrs
VP, Global Operations |
8,644 | 1,481 | 21,558 $625,182 | 5 |
Feb 27, 2024
Reduced 1.55%
|
|
Robert C Thomson
VP Research & Development |
13,291 | 0 | 13,291 $385,439 | 2 |
Feb 23, 2024
Added 38.05%
|